wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37728501-A95E618A-3403-4D78-9088-5633F9BB9684
Q37728501-A95E618A-3403-4D78-9088-5633F9BB9684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37728501-A95E618A-3403-4D78-9088-5633F9BB9684
Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis.
P2860
Q37728501-A95E618A-3403-4D78-9088-5633F9BB9684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37728501-A95E618A-3403-4D78-9088-5633F9BB9684
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fe8122ff62e0e805dae80862829d6876c16f0cc0
P2860
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.